Original Research
Accepted on 16 Feb 2026
A Pathological Classification for Predicting Recurrence and Guiding Adjuvant Therapy in Esophageal Squamous Cell Carcinoma following Neoadjuvant Immunochemotherapy: a Two-Center Cohort Study
in Gastrointestinal Cancers: Gastric and Esophageal Cancers